Publications by authors named "Anyun Ma"

We investigated the mechanism by which ACE2 (angiotensin-converting enzyme 2) overexpression alters neurohumoral outflow and central oxidative stress. Nrf2 (nuclear factor [erythroid-derived 2]-like 2) is a master antioxidant transcription factor that regulates cytoprotective and antioxidant genes. We hypothesized that upregulation of central ACE2 inhibits the pressor response to Ang II (angiotensin II) by reducing reactive oxygen species through a Nrf2/antioxidant enzyme-mediated mechanism in the rostral ventrolateral medulla.

View Article and Find Full Text PDF

Nuclear factor E2-related factor 2 (Nrf2) is a key transcription factor that maintains redox homeostasis by governing a broad array of antioxidant genes in response to oxidant stress. We hypothesized that overexpression of Nrf2 in the rostral ventrolateral medulla (RVLM) ameliorates sympatho-excitation in mice with coronary artery ligation-induced chronic heart failure (CHF). To address this, we overexpressed Nrf2 in the RVLM using an HIV-CamKIIa-Nrf2 lenti virus in C57BL/6 mice.

View Article and Find Full Text PDF

Tetralogy of Fallot (TOF) is the most common cyanotic form of congenital heart defects (CHDs). The right ventricular hypertrophy is associated with the survival rate of patients with repaired TOF. However, very little is known concerning its genetic etiology.

View Article and Find Full Text PDF

Neurons and glia cells are differentiated from neural stem/progenitor cells (NSCs/NPCs) during brain development. Concomitant activation of JAK/STAT and NOTCH1 signaling is required for gliogenesis, a process to generate glia cells to ensure proper brain functions. NOTCH1 signaling is down-regulated during neurogenesis and up-regulated during gliogenesis.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Anyun Ma"

  • - Anyun Ma's recent research primarily focuses on the role of Nrf2 (nuclear factor [erythroid-derived 2]-like 2) in regulating oxidative stress and sympathetic nervous system activity in cardiovascular conditions, especially chronic heart failure and responses to angiotensin II.
  • - One significant finding indicated that overexpression of central ACE2 could inhibit the pressor response to angiotensin II by reducing oxidative stress through an Nrf2-mediated mechanism, highlighting potential therapeutic targets for hypertension.
  • - Additional research into genetic factors of congenital heart defects, specifically Tetralogy of Fallot (TOF), has explored the association of mutations with right ventricular hypertrophy, contributing to the understanding of the genetic basis of these conditions.